1.FTY720 reduces peritubular micrangium loss in renal interstitial fibrotic rats.
Chinese Journal of Pediatrics 2009;47(6):468-470
Animals
;
Apoptosis
;
drug effects
;
Capillaries
;
pathology
;
Fibrosis
;
Fingolimod Hydrochloride
;
Kidney Diseases
;
metabolism
;
pathology
;
Kidney Tubules
;
blood supply
;
Male
;
Propylene Glycols
;
pharmacology
;
therapeutic use
;
Rats
;
Rats, Sprague-Dawley
;
Sphingosine
;
analogs & derivatives
;
pharmacology
;
therapeutic use
;
Vascular Diseases
;
prevention & control
2.Myxoinflammatory fibroblastic sarcoma: report of a case.
Chinese Journal of Pathology 2010;39(1):57-58
Aged, 80 and over
;
Antigens, CD
;
metabolism
;
Antigens, Differentiation, Myelomonocytic
;
metabolism
;
Diagnosis, Differential
;
Fasciitis
;
pathology
;
Fibroblasts
;
pathology
;
Fibrosarcoma
;
metabolism
;
pathology
;
surgery
;
Forearm
;
Histiocytoma, Malignant Fibrous
;
pathology
;
Humans
;
Male
;
Myxosarcoma
;
metabolism
;
pathology
;
surgery
;
Soft Tissue Neoplasms
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
;
alpha 1-Antichymotrypsin
;
metabolism
4. Chemical constituents from Pinus yunnanensis
Chinese Traditional and Herbal Drugs 2017;48(18):3693-3697
Objective To study the chemical constituents of Pinus yunnanensis. Methods The whole plant of air-dried P. yunnanensis was extracted with methnol. The methnol extract was suspended in H2O and extracted with petroleum, ethyl acetate, and n-BuOH, successively. The compounds were isolated and purified by column chromatography from the petroleum and ethyl acetate fractions, and identified based on spectral analyses (MS, 1D- and 2D-NMR, IR, UV). Results Fourteen compounds were isolated from P. yunnanensis and characterized as (7R,8R)-7,8-dihydro-3'-hydroxyl-7-(4-hydroxyl-3-methoxyphenyl)-8-hydroxymethyl-1'-benzofuranpropanol- 4-O-(3-O-methyl-α-L-rhamnopyranoside) (1), pinosylvine (2), stigmast-4-en-3-one (3), kaempferol (4), isopimarinol (5), quercetin (6), pinocembrin (7), taxifilin (8), 3-hydroxyl-5-methoxy-stilbene (9), 5-O-β-D-glucopyranosyl-thymoquinol (10), icariside E4 (11), 3,4-dimethoxyphenyl-1-O-β-D-glucopyranoside (12), schizandriside (13), and β-stitosterol (14). Conclusion Compounds 1, 3-7, and 10-13 are obtained from Pinus yunnanensis Lamb. for the first time.
5. Purification technology of salidroside by microporous adsorption resin
Chinese Traditional and Herbal Drugs 2013;44(11):1426-1430
Objective: To optimize the purification technology of salidroside with macroporous adsorption resin. Methods: The absorption and elution conditions of salidroside purificatin by various macroporous adsorption resins were investigated with the content of salidroside as index. Results: SP-825 type macroporous adsorption resin was the best choice for the purification of salidroside. The optimized parameters were as follows: the content of salidroside at 1.713-2.570 g/mL, eluting solvent of 10% aqueous ethanol, volume flow at 2 BV/h, and eluant volume at 30 BV. Conclusion: SP-825 type macroporous adsorption resin could significantly increase the purity of salidroside with the advantage of high absorption, high elution rate, low cost, environment friendly, and being applicable for the production in large scale.
6.Academic connotation of"pathogenic factors"in Huang Di Nei Jing
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(08):-
The academic connotation of "pathogenic factors" is discussed in this article from three aspects of etiology,diagnosis and treatment.It is considered that endogenous or exogenous pathogenic factors oppose to and destruct healthy energy.TCM pathogenic factors,obtained from "examining syndromes for causes of diseases",are diverged from physical,chemical and biological those in modern medicine.What is meant by "therapy of expelling pathogenic factors" is not a single method of dispelling toxin and killing germs,but the resort of regulating the integrated abilities of the human body fighting against pathogenic factors.
7.Continuous intravenous infusion of midazolam for treatment of status epilepticus in children.
Jian-min ZHONG ; Jian-hua LI ; Yong CHEN
Chinese Journal of Pediatrics 2004;42(4):299-300
Adolescent
;
Age Factors
;
Anti-Anxiety Agents
;
administration & dosage
;
adverse effects
;
therapeutic use
;
Child
;
Child, Preschool
;
Female
;
Humans
;
Infant
;
Infusions, Intravenous
;
Male
;
Midazolam
;
administration & dosage
;
adverse effects
;
therapeutic use
;
Status Epilepticus
;
drug therapy
;
Treatment Outcome